Espana F - Search Results

1

Plasminogen activators and plasminogen activator inhibitors in endometriosis.

Gilabert-Estelles J, Castello R, Gilabert J, Ramon LA, Espana F, Romeu A, Estelles A. Gilabert-Estelles J, et al. Among authors: espana f. Front Biosci. 2005 May 1;10:1162-76. doi: 10.2741/1609. Front Biosci. 2005. PMID: 15769615 Review.

2

Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.

Castelló R, Landete JM, España F, Vázquez C, Fuster C, Almenar SM, Ramón LA, Radtke KP, Estellés A. Castelló R, et al. Among authors: espana f. Thromb Res. 2007;120(5):753-62. doi: 10.1016/j.thromres.2006.12.016. Epub 2007 Jan 29. Thromb Res. 2007. PMID: 17258797

3

Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.

Ramón LA, Gilabert-Estellés J, Cosín R, Gilabert J, España F, Castelló R, Chirivella M, Romeu A, Estellés A. Ramón LA, et al. Among authors: espana f. Thromb Res. 2008;122(6):854-60. doi: 10.1016/j.thromres.2008.02.010. Epub 2008 Apr 18. Thromb Res. 2008. PMID: 18423526

4

Fibrinolysis: the key to new pathogenetic mechanisms.

Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A. Zorio E, et al. Among authors: espana f. Curr Med Chem. 2008;15(9):923-9. doi: 10.2174/092986708783955455. Curr Med Chem. 2008. PMID: 18473800 Review.

5

Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy.

Estellés A, Gilabert J, Andrés C, España F, Aznar J. Estellés A, et al. Among authors: espana f. Thromb Haemost. 1990 Oct 22;64(2):281-5. Thromb Haemost. 1990. PMID: 2125378

6

Clinical and haemostatic parameters in the HELLP syndrome: relevance of plasminogen activator inhibitors.

Gilabert J, Estellés A, Ridocci F, España F, Aznar J, Galbis M. Gilabert J, et al. Among authors: espana f. Gynecol Obstet Invest. 1990;30(2):81-6. doi: 10.1159/000293222. Gynecol Obstet Invest. 1990. PMID: 2147163

7

Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation.

Gilabert J, Estellés A, Ayuso MJ, España F, Chirivella M, Grancha S, Micó JM, Aznar J. Gilabert J, et al. Among authors: espana f. Gynecol Obstet Invest. 1994;38(3):157-62. doi: 10.1159/000292470. Gynecol Obstet Invest. 1994. PMID: 8001867

8

Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis.

Gilabert-Estellés J, Estellés A, Gilabert J, Castelló R, España F, Falcó C, Romeu A, Chirivella M, Zorio E, Aznar J. Gilabert-Estellés J, et al. Among authors: espana f. Hum Reprod. 2003 Jul;18(7):1516-22. doi: 10.1093/humrep/deg300. Hum Reprod. 2003. PMID: 12832381

9

mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay.

Ramón L, Gilabert-Estellés J, Castelló R, Gilabert J, España F, Romeu A, Chirivella M, Aznar J, Estellés A. Ramón L, et al. Among authors: espana f. Hum Reprod. 2005 Jan;20(1):272-8. doi: 10.1093/humrep/deh571. Epub 2004 Dec 3. Hum Reprod. 2005. PMID: 15579491

10

Expression of the fibrinolytic components in endometriosis.

Gilabert-Estelles J, Ramon LA, España F, Gilabert J, Castello R, Estelles A. Gilabert-Estelles J, et al. Among authors: espana f. Pathophysiol Haemost Thromb. 2006;35(1-2):136-40. doi: 10.1159/000093556. Pathophysiol Haemost Thromb. 2006. PMID: 16855359 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters